Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

The maternally transcribed gene p57(KIP2) (CDNK1C) is abnormally expressed in both androgenetic and biparental complete hydatidiform moles.

Fisher RA, Hodges MD, Rees HC, Sebire NJ, Seckl MJ, Newlands ES, Genest DR, Castrillon DH.

Hum Mol Genet. 2002 Dec 15;11(26):3267-72.

PMID:
12471053
2.

Complete hydatidiform mole retaining a chromosome 11 of maternal origin: molecular genetic analysis of a case.

Fisher RA, Nucci MR, Thaker HM, Weremowicz S, Genest DR, Castrillon DH.

Mod Pathol. 2004 Sep;17(9):1155-60.

3.

The product of the imprinted gene IPL marks human villous cytotrophoblast and is lost in complete hydatidiform mole.

Saxena A, Frank D, Panichkul P, Van den Veyver IB, Tycko B, Thaker H.

Placenta. 2003 Sep-Oct;24(8-9):835-42.

PMID:
13129680
4.

Complete hydatidiform mole with retained maternal chromosomes 6 and 11.

McConnell TG, Norris-Kirby A, Hagenkord JM, Ronnett BM, Murphy KM.

Am J Surg Pathol. 2009 Sep;33(9):1409-15. doi: 10.1097/PAS.0b013e3181a90e01.

PMID:
19542869
5.

p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.

Sebire NJ, Rees HC, Peston D, Seckl MJ, Newlands ES, Fisher RA.

Histopathology. 2004 Aug;45(2):135-41.

PMID:
15279631
6.

Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping.

Banet N, DeScipio C, Murphy KM, Beierl K, Adams E, Vang R, Ronnett BM.

Mod Pathol. 2014 Feb;27(2):238-54. doi: 10.1038/modpathol.2013.143. Epub 2013 Jul 26.

8.

The usefulness of p57(KIP2) immunohistochemical staining and genotyping test in the diagnosis of the hydatidiform mole.

Landolsi H, Missaoui N, Brahem S, Hmissa S, Gribaa M, Yacoubi MT.

Pathol Res Pract. 2011 Aug 15;207(8):498-504. doi: 10.1016/j.prp.2011.06.004. Epub 2011 Jul 20.

PMID:
21767919
9.

Simultaneous detection of imprinted gene expression (p57(KIP2)) and molecular cytogenetics (FICTION) in the evaluation of molar pregnancies.

Hoffner L, Parks WT, Swerdlow SH, Carson JC, Surti U.

J Reprod Med. 2010 May-Jun;55(5-6):219-28.

PMID:
20626178
10.

Genomic imprinting in gestational trophoblastic disease--a review.

Fisher RA, Hodges MD.

Placenta. 2003 Apr;24 Suppl A:S111-8. Review.

PMID:
12842422
11.

Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2.

Castrillon DH, Sun D, Weremowicz S, Fisher RA, Crum CP, Genest DR.

Am J Surg Pathol. 2001 Oct;25(10):1225-30.

PMID:
11688455
12.

Genetic origin and imprinting in hydatidiform moles. Comparison between DNA polymorphism analysis and immunoreactivity of p57KIP2.

Kihara M, Matsui H, Seki K, Nagai Y, Wake N, Sekiya S.

J Reprod Med. 2005 May;50(5):307-12.

PMID:
15971478
13.

p57KIP2 immunohistochemistry in early molar pregnancies: emphasis on its complementary role in the differential diagnosis of hydropic abortuses.

Merchant SH, Amin MB, Viswanatha DS, Malhotra RK, Moehlenkamp C, Joste NE.

Hum Pathol. 2005 Feb;36(2):180-6.

PMID:
15754295
14.

Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.

Lewis GH, DeScipio C, Murphy KM, Haley L, Beierl K, Mosier S, Tandy S, Cohen DS, Lytwyn A, Elit L, Vang R, Ronnett BM.

Int J Gynecol Pathol. 2013 Mar;32(2):199-214. doi: 10.1097/PGP.0b013e3182630d8c.

PMID:
23370656
15.

Recurrent biparental hydatidiform mole: additional evidence for a 1.1-Mb locus in 19q13.4 and candidate gene analysis.

Panichkul PC, Al-Hussaini TK, Sierra R, Kashork CD, Popek EJ, Stockton DW, Van den Veyver IB.

J Soc Gynecol Investig. 2005 Jul;12(5):376-83.

PMID:
15979551
16.

Familial recurrent hydatidiform mole: a review.

Fisher RA, Hodges MD, Newlands ES.

J Reprod Med. 2004 Aug;49(8):595-601. Review.

PMID:
15457849
17.

Analysis of the chromosomal region 19q13.4 in two Chinese families with recurrent hydatidiform mole.

Zhao J, Moss J, Sebire NJ, Cui QC, Seckl MJ, Xiang Y, Fisher RA.

Hum Reprod. 2006 Feb;21(2):536-41. Epub 2005 Oct 20.

PMID:
16239310
18.

[Clinical characteristics and genetic analyses of familial recurrent moles].

Zhao J, Xiang Y, Huang SZ, Wan XR, Dong M, Hu SY, He LZ, Yang XY.

Zhonghua Fu Chan Ke Za Zhi. 2006 Mar;41(3):177-81. Chinese.

PMID:
16640884
19.

Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach.

McConnell TG, Murphy KM, Hafez M, Vang R, Ronnett BM.

Am J Surg Pathol. 2009 Jun;33(6):805-17. doi: 10.1097/PAS.0b013e318191f309. Erratum in: Am J Surg Pathol. 2009 Aug;33(8):1258.

PMID:
19145201
20.

Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease.

Chilosi M, Piazzola E, Lestani M, Benedetti A, Guasparri I, Granchelli G, Aldovini D, Leonardi E, Pizzolo G, Doglioni C, Menestrina F, Mariuzzi GM.

Lab Invest. 1998 Mar;78(3):269-76.

PMID:
9520940

Supplemental Content

Support Center